Monday, August 17, 2026

Search
HomeBusiness NewsHumanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors...
Business News

Humanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors following presenta…

0
2
- Advertisement -


BURLINGAME, Calif.–()–Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company, today announced its research partners will present Phase 1 results from a study of ifabotuzumab in glioblastoma multiforme (GBM) at the Annual Congress of the European…



Click here to view the original article.

- Advertisment -
Previous article
American Express Reports Third-Quarter Revenue of $10.9 Billion and Earnings Per Share Of $2.27
Next article
Kosmos Energy to Host Third Quarter 2021 Results and Webcast on November 08, 2021

RELATED ARTICLES

- Advertisement -

Recently Viewed

Load more

FEATURED

POPULAR POSTS

POPULAR CATEGORY

The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

FOLLOW US

© 2024 Australian Online News | Privacy Policy